# A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems

> **NCT00002304** · NA · COMPLETED · sponsor: **Pfizer**

## Conditions studied

- Candidiasis, Esophageal
- HIV Infections

## Interventions

- **DRUG:** Ketoconazole
- **DRUG:** Fluconazole

## Key facts

- **NCT ID:** NCT00002304
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002304, "A Comparison of Fluconazole and Ketoconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*